MHA Keystone: Intensive Care Unit (ICU)
According to the Centers for Disease Control and
Prevention, roughly 41,000 central-line-associated bloodstream infections
(CLABSIs) occur in U.S. hospitals each year. These infections, many
of which are preventable, result in thousands of deaths and billions
of dollars in added healthcare costs each year.
What We Are Doing
Michigan hospitals continue to improve CLABSI and ventilator-associated event rates and recently began reporting infection-related ventilator-associated complications. Participating hospitals are also implementing prevention, detection and treatment strategies to reduce sedation and delirium in the ICU. This year, 13 Michigan hospitals joined the first cohort of the CUSP for Mechanically Ventilated Patients — Ventilator Associated Pneumonia (CUSP 4 MVP-VAP) initiative, a national program to improve outcomes for ventilated patients.
MHA Keystone: ICU CLABSI Data
By reviewing patient safety
and quality information, consumers can make better educated choices
about their healthcare. It is crucial to the overall well-being of patients
that they concentrate on their health and recovery and trust that their
care providers are committed to safety and transparency. The release
of data is one way to illustrate that commitment to patients and to
facilitate trusting hospital-patient relationships.
This data is categorized by ICU type - burn, coronary, medical, medical/surgical
major teaching, medical/surgical, neurosurgical, surgical, surgical
cardiothoracic and trauma. The rate is reported as the number of CLABSIs
per 1,000 central-line days and is calculated by dividing the number
of CLABSIs by the number of central-line days and multiplying the result
by 1,000. Lower rates signify better outcomes. Pediatric rates are not
included because the MHA Keystone Center has not captured data for these
Opportunity Estimator Tool
The Opportunity Estimator is a tool designed to engage clinicians
and hospital leadership, educate staff about preventable harm and avoidable
costs, and evaluate the impact of performance on financial and clinical
outcomes, such as infection rates in the ICU. Published estimates of
mortality and costs associated with CLABSIs are used to translate a
hospital's individual CLABSI rate into the number of potentially preventable
deaths, excess dollars and excess ICU days. In addition, the tool estimates
the potential savings in deaths, dollars and ICU days based on graduated
reductions in CLABSI rates from participating in a CLABSI intervention.